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ABSTRACT 
Objective: The present study was undertaken to evaluate the role of exercise and dietary manipulation in obese rats treated with Orlistat. 
Methods: The study was conducted for 16 weeks. High-fat diet (HFD) was used to induce obesity, and once these animals were obese (eight week), 
manipulation in the diet, exercise, Orlistat and low dose of Orlistat were tested for 8 more weeks. During the treatment period, animals were 
continued with HFD except for the groups where the low-calorie diet (LCD) was used. The various manipulative options studied to include 
swimming test (physical exercise), Orlistat (200 mg/kg), low dose Orlistat (65 mg/kg) and low-calorie diet. The parameters were evaluated 
including Body weight was measured on weekly two days. Biochemical parameters such as HDL, LDL, VLDL, Triglycerides and total cholesterol were 
measured using diagnostic kits. Blood-glucose level was measured. On 16th
Results: There was a significant reduction in body weight, Triglycerides, total cholesterol, LDL, VLDL, Blood-glucose level organ weights included 
the Liver, Left kidney and Right kidney and fat pad weights such as Mesenteric fat, Epididymis fat and increased in HDL level of the animals treated 
with exercise and dietary manipulation and Orlistat. 
 week, the animals were sacrificed and their organ weights were 
measured. Organ weights included the Liver, Left and Right kidney and fat pad weights such as Mesenteric fat, Epididymis fat.  
Conclusion: The present study revealed that [HFD+Orlistat (low dose)+Exercise+LCD] group showed more potential effective than rest of all 
treatment groups.  
Keywords: Anti-obesity, High-fat diet, Low-calorie diet, Exercise, Orlistat. 
 
INTRODUCTION 
Obesity is a medical condition in which excess body fat gets 
accumulated to the extent that it may have an adverse effect on 
health, leading to reduced life expectancy and/or increased health 
problems. Among the multiple factors contributing to its etiology, 
the sedentary life styles, white-collar jobs, lack of exercise, 
psychological factors, and the consumption of energy-rich diets are 
the major ones [1, 2].  
Due to obscure etiology, the treatment of obesity is difficult and 
challenging. Further, the cause of concern is the non-availability of 
drugs for its treatment and the short-term efficacy and limiting side 
effects of the available drug [3]. 
It is the accumulation of body fat to the level which might have a 
negative effect on health. Body Mass Index (BMI) is a widely used 
diagnostic tool which provides a simple numeric measure of people 
‘fatness’. BMI of 18.5 to 25 may indicate optimal weight a number 
above 25 may indicate the person is overweight; while a number 
above 30 suggests the person is obese and over 40, indicates 
morbidly obese. Indian urban population is experiencing high rates 
of obesity, as their work often demands less physical exertion. Even 
rural areas are not immune because of increased mechanization of 
farming activity leading to reduced physical activity [4].  
The prevalence of obesity is increasing worldwide. Numerous 
diseases are caused or made worse by obesity. These include type 
two diabetes; hypertension; dyslipidemia; ischemic heart disease; 
stroke; obstructive sleep apnea; asthma; non alcoholic steato 
hepatitis; gastro esophageal reflux disease; degenerative joint 
disease of the back, hips, knees, and feet; infertility and poly cystic 
ovary syndrome; various malignancies; and depression [5].  
A compound that selectively limits the intestinal absorption of 
dietary fat, in excess of that manageable by dietary manipulation 
alone, could become a useful therapeutic agent for the treatment of 
obesity. The inhibition of gastrointestinal lipase may be a potential 
method for decreasing fat absorption. Pancreatic lipase is the key 
enzyme required for the absorption of dietary triglyceride. 
Pancreatic lipase may also be indirectly responsible for an 
absorption of cholesterol. 
Orlistat is a pharmacological agent that promotes weight loss in 
obese subjects via inhibiting of gastric and pancreatic lipase, an 
enzyme that is crucial for the digestion of the long-chain 
triglycerides, which at three daily doses of 120 mg reduces fat 
absorption by 30% and has been proven to be useful in facilitating 
both weight loss and weight maintenance [6]. 
However, because Orlistat can result in undesirable side effects, such 
as fecal incontinence, flatulence, and steatorrhea, its use may be 
limited. Therefore, it may be worthwhile to search the natural 
substances that show potent inhibitory activity against pancreatic 
lipase and have fewer side effects [7]. 
Increasing dietary fat increases body fat and it is unlikely that 
humans escape this important biological rule. Increasing dietary fat 
is associated with increased prevalence of obesity probably by 
increasing the intake of energy dense foods.  
In the National Weight Loss Registry, three things were associated 
with weight loss: continued monitoring of food intake, lowering 
dietary fat intake, and increased exercise. The relation of dietary fat 
is most evident when physical activity is low [8]. 
Physical exercise can be used effectively by itself or in combination 
with dietary restriction to trigger weight loss [9]. Hence, the present 
study is designed to evaluate the effect of dietary manipulation and 
exercise in the management of obesity in Orlistat treated rats. 
MATERIALS AND METHODS 
Chemicals and reagents 
Triglyceride and Cholesterol Kit (Span Diagnostics, Bangalore, 
India), Orlistat Capsules 120 mg (Torrent Pharmaceuticals LTD, 
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India). All other reagents used in the experiments were of analytical 
grade and of the high purity. 
 
Table 1: Composition of experimental diets 
Composition of diet High-fat diet 
(HFD) in gm 
Low-calorie diet 
LCD) in gm 
1. Fat:    
a. Lard  230 0 
b. Vegetable oil 50 45 
2. Carbohydrate:    
a. Dextrin 97 95 
b. Cornstarch 98 95 
c. Sucrose 130 445 
3. Protein:    
a. Casein 325 250 
4. Vitamin mix 30 30 
5. Mineral mix 40 40 
6. total weight(g) 1000 1000 
7. Energy density(k cals) 5.15 3.93 
8. % Macronutrient(k cals)   
a. Fat  50 10 
b. Carbohydrate 25 65 
c. protein 25 25 
Ingredients expressed by weight (gm), HFD (high-fat diet); LCD 
(low-calorie diet) 
 
Description of diet [10] 
Animals 
Female Sprague-Dawley rats were obtained from the Central Animal 
house, Krupanidhi College of Pharmacy, Bangalore, India. The rats 
were housed under 22±2ºC temperatures, 40-60% humidity and 12-
12±1 h light-dark cycle. During obesity induction, rats weighing 150-
200g were taken for the study, and they were broadly divided into 
ten groups. Group one was normal control (Normal pellet diet was 
fed) and nine groups were fed with HFD (High-fat diet) to induce 
obesity and water ad libitum. Experimental protocols were followed 
as per Institutional Animal Ethical committee guidelines. Animal 
Ethical committee clearance (CPCSEA No. KCP/IAEC-005/2013-14) 
was obtained for the procurement of animals. 
Experimental design 
The SD female rats were divided into 10 major groups. Each of the 
subgroups consists of six animals as follows:  
1. Normal Control-Rats will be fed on normal pellet diet 
2. HFD Control-Rats will be fed on high-fat diet [11] 
3. HFD+Exercise [12] 
4. HFD+Low-calorie diet-(Obese rats will be switched from HFD 
to LCD) [11] 
5. HFD+LCD+Exercise 
6. HFD+Orlistat (200 mg/kg diet) [13] 
7. HFD+Orlistat (low dose) (100 mg/kg) 
8. HFD+Orlistat (low dose)+Exercise 
9. HFD+Orlistat (low dose)+LCD 
10. HFD+Orlistat (low dose)+LCD+Exercise 
Exercise protocols [12] 
Swimming 
The rats will be adapted to the water before the training began. The 
adaptation will consist of swimming for 30 minutes, once per day for 
five days, in water at a temperature of 31 °C. After adaptation, the 
rats will be trained by swimming for 60 minutes/day, five days a 
week for eight weeks, with a constant overload equivalent to 5% of 
their body weight. The water tanks will be 50 cm in height and 30 
cm in diameter, and the over load (lead fish sinkers) was attached to 
the animal’s chest using an appropriate vest. 
Measurement of body weight 
Body weight was measured on every alternative day for 16 weeks. 
Estimation of plasma lipid profiles 
At the end of the experiment, on 16th-week blood samples were 
collected from overnight fasted animals under inhalation of 
anesthesia by retro-orbital puncture method. Plasma was separated 
by centrifugation at 2500 rpm for 15 min and was used for further 
experiments, i.e. Total cholesterol, HDL and triglyceride levels were 
estimated by CHOD-PAP method and GPO-PAP method. LDL levels 
were calculated by the method of Johnson et al.[14]. Blood glucose is 
estimated by using Glucometer. 
Estimation of organ weight and fat pad weight 
On 16th
Statistical analysis 
The results will be expressed as mean±SEM. Comparisons between 
the treatment groups and control will be performed by analysis of 
variance (ANOVA) followed by Turkeys’ multiple range tests. In all 
tests, the criterion for statistical significance will be (p<0.05). 
RESULTS 
Body weight 
-week the animals were sacrificed by cervical dislocation and 
organs like Liver and kidney weights has taken. Fat pads like 
Mesenteric and epididymal fat are collected and dried on filter paper 
and weighed. 
High-Fat Diet substantially increased body weights of rats in 16th-
week, when compared to the normal control group. On 16th
 
-week, 
when compared to HFD control, all Treatment groups showed a 
significant decrease in body weight. [HFD+Orlistat (low 
dose)+Exercise+LCD] group showed more potential effective than 
rest of all treatment groups (table 2). 
Table 2: Effect of exercise and dietary manipulation on body weight 
S. No. Experiment groups 1 Week 8 Week 16 Week 
1 Normal control 150±1.91 200.16±3.24 260.83±2.7 
2 HFD (high-fat diet) control 153.3±2.94 250.33±3.16 350.5±4.52a 
3 
a 
HFD+Exercise 152.17±3.1 253.67±3.40 330±3.21a 
4 
a,x 
HFD+LCD (low-calorie diet) 154.67±2.64 252.83±4.54 345.5±3.62a 
5 
a 
HFD+LCD+Exercise 151.5±3.15 255.67±3.20 325±2.83a 
6 
a,x 
HFD+Orlistat  150.17±1.85 248±2.42 335.83±2.97a 
7 
a,x 
HFD+Orlistat (low dose) 153.3±2.60 251.67±3.92 342.17±3.15a 
8 
a,y 
HFD+Orlistat (low dose)+Exercise 150.3±3.09 254.17±4.35 322.33±2.53a 
9 
a,x 
HFD+Orlistat (low dose)+LCD 152.67±3.05 250.83±2.74 339±2.97a 
10 
a,y 
HFD+Orlistat (low dose)+LCD+Exercise 154.17±2.37 253±2.11 318.33±4.11a a,x 
All values are mean±SEM. aP<0.001, bP<0.01, cP<0.05 When compared to the normal control group, xP<0.001, yp<0.01, zp<0.05 When compared to 
HFD control. 
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Table 3: Effect of exercise and dietary manipulation on bio chemical parameters 
S. 
No. 
Experiment groups Triglycerides Cholesterol HDL LDL VLDL Blood 
glucose  
1 Normal control 96±2.07  67.50±1.84  50.3±2.19 35.3±1.31 20.67±0.8 100±1.63 
2 HFD (high-fat diet) control 151.17±1.96 143.17±2.14a 25.3±1.38a 60.5±0.76a 35.5±2.78a 150.1±2.02a 
3 
a 
HFD+Exercise 130.8±2.41 118.5±1.09a,x 37.5±1.87a,x 46.17±1.87a,y 25.5±1.95a 133±2.8z 
4 
a,x 
HFD+LCD (low-calorie diet) 145.83±2.73 138.17±1.01b 30.3±1.72a 55.17±1.51a 32.17±1.6a 145.5±1.95b 
5 
a 
HFD+LCD+Exercise 125.17±1.6 116.17±2.5a,x 38.6±0.84a,x 47.83±1.78b,x 24.3±1.5a,x 128.8±1.87y 
6 
a,x 
HFD+Orlistat  135.8±2.75 121±1.37a,y 36.3±2.23a,x 43.17±2.3a,y 26.6±1.97x 137.1±1.8z 
7 
a,y 
HFD+Orlistat (low dose) 143.67±2.03 135±1.24a 31.6±2.47a,z 53±2.19a 31±1.59a 144±1.57b 
8 
a 
HFD+Orlistat (low dose)+Exercise 109.6±3.28 111±1.50a,x 41.16±0.94a,x 39±1.65c,x 19.5±1.54x 126.8±1.6x 
9 
a,x 





105.3±4.41 100.50±1.84x 45.83±2.03a,x 29.67±1.43x 18.3±1.28x 123.3±2.7x a,x 
All values are mean±SEM aP<0.001, bP<0.01, cP<0.05 When compared to the normal control group, xP<0.001, yp<0.01, z
 
p<0.05 When compared to 
HFD control. 
Table 4: Effect of exercise and dietary manipulation on organ fat pad weight 
S. No. Experiment groups Epididymal Fat (gm) Mesentric Fat (gm) 
1 Normal control 3.27±0.27 2.56±0.21 
2 HFD (high-fat diet) control 8.25±0.23 7.31±0.27a 
3 
a 
HFD+Exercise 4.69±0.50 4.94±0.29x 
4 
a,x 
HFD+LCD (low-calorie diet) 7.57±0.22 6.95±0.18a 
5 
a 
HFD+LCD+Exercise 4.52±0.23 4.56±0.32x 
6 
a,x 
HFD+Orlistat  5.21±0.17 5.24±0.24b,x 
7 
a,x 
HFD+Orlistat (low dose) 7.34±0.33 6.23±0.23a 
8 
a 
HFD+Orlistat (low dose)+Exercise 3.74±0.48 4.41±0.23 x 
9 
a,x 
HFD+Orlistat (low dose)+LCD 6.41±0.32 5.65±0.22a,y 
10 
a,y 
HFD+Orlistat (low dose)+LCD+Exercise 3.7±0.38 4.35±0.38x a,x 
All values are mean±SEM aP<0.001, bP<0.01, cP<0.05 When compared to the normal control group, xP<0.001, yp<0.01, z
 
p<0.05 When compared to 
HFD control. 
Table 5: Effect of exercise and dietary manipulation on organ weight 
S. No. Experiment groups Right kidney WT (g) Left kidney WT (g) Liver WT (g) 
1 Normal control  0.75±0.04  0.73±0.03  6.03±0.33  
2 HFD (high-fat diet) control  1.65±0.04  1.62±0.05a  11.3±0.3a 
3 
a 
HFD+Exercise 1.22±0.03 1.30±0.03a,x 9.63±0.56a,x 
4 
a 
HFD+LCD (low-calorie diet) 1.42±0.03 1.48±0.04a,y 10.65±0.39a 
5 
a 
HFD+LCD+Exercise 1.05±0.04 1.20±0.06a,x 9.35±0.59a,x 
6 
a,z 
HFD+Orlistat  1.29±0.03 1.33±0.03a,x 10.03±0.27a,y 
7 
a 
HFD+Orlistat (low dose) 1.41±0.02 1.45±0.03 a,y 10.33±0.26a 
8 
a 
HFD+Orlistat (low dose)+Exercise 1.02±0.06 0.26±0.07a,x 9.28±0.37a,x 
9 
a,x 
HFD+Orlistat (low dose)+LCD 1.35±0.07 1.34±0.03a,x 10.22±0.34a,y 
10 
a 
HFD+Orlistat (low dose)+LCD+Exercise 1.15±0.04 1.18±0.05a,x 923±0.4a,x a,x 
All values are mean±SEM. aP<0.001, bP<0.01, cP<0.05 When compared to the normal control group, xP<0.001, yp<0.01, z
 
p<0.05 When compared to 
HFD control. 
Serum lipid profiles 
Rats fed with HFD showed increased levels of serum Triglycerides, 
LDL, VLDL and total cholesterol and decreased HDL levels, when 
compared normal control. All Treatments groups showed 
significantly suppressed the rise of Lipid profile and rise in the HDL 
levels was observed. [HFD+Orlistat (low dose)+Exercise+LCD] group 
showed more potential effective than rest of all treatment groups 
(table 3). 
Blood glucose 
Treatment groups showed a significant decrease in blood-glucose 
levels when compared to the HFD control group. [HFD+Orlistat (low 
dose)+Exercise+LCD] group showed more potential effective than 
rest of all treatment groups (table 3). 
Organ weight and Fat pad analysis 
Treatment groups showed a significant activity in decreasing the 
organ weight and Fat pad weights [HFD+Orlistat (low 
dose)+Exercise+LCD] group showed more potential effective than 
rest of all treatment groups (table 4 and 5). 
DISCUSSION 
The present study was designed to evaluate the role of exercise and 
dietary manipulation on the markers of obesity in rats. The study was 
conducted for 16 weeks High-fat diet (HFD) was used to induce 
obesity and once the animal, were obese (eight week), manipulation in 
diet, exercise, dose of Orlistat was tested for 8 more weeks. During the 
treatment period animals were continued with HFD except for the 
groups where the low-calorie diet (LCD) was used. The various 
manipulative options studied to include swimming test (physical 
exercise), low dose Orlistat (65 mg/kg) and low-calorie diet. 
The parameters evaluated in this include body weight, biochemical 
parameters such as HDL, LDL, VLDL, triglycerides and total cholesterol 
measured using diagnostic kits, blood-glucose level measured by using 
glucometer. On 16th week, the animals were sacrificed and their organ 
weights were measured, such as the liver, left kidney and right kidney 
and fat pad weights such mesenteric fat, epididymis fat.  
Obesity is a metabolic disorder characterized by an excessive 
accumulation of fat in the body to an extent which adversely affects 
the health of an individual. It is a direct consequence of perpetual 
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imbalance between energy intake and expenditure with storage of 
extra calories in the form of fat in the adipose tissue. In obesity, 
there is an increase in intake of high-fat and high-energy food and a 
decrease in daily energy expenditure [4]. 
Diet and physical exercise remain as the main stay in obesity 
management; nonetheless, anti-obesity drugs may be required 
either to reduce appetite or to inhibit fat absorption. Various factors 
are found to be involved in obesity, including the genetic, 
environmental, behavioral, and socio-economic factors. 
The present study indicated that administration of HFD to the animals 
for eight weeks significantly (P<0.001) increased body weight, LDL, 
TG, VLDL, blood-glucose level, weights of liver, left kidney, right 
kidney, mesenteric fat, epididymis fat and reduced the HDL level 
compared to normal control (table 1-4). HFD is a standard diet widely 
used experimentally to induce obesity in animals. The composition of 
HFD contains pork fat, glucose, casein, Nacl, dextrin. Earlier research 
indicated that expose of these ingredients to the experimental animals 
alters the metabolic mechanisms resulting in obesity. The data 
indicated that HFD induced obesity is due to hyperlipidemia, and 
hyperglycemia were evidence by a gain in body weight, increase in 
triglyceride levels and as well as increasing in the glucose levels [15]. 
Our observation also indicates that HFD administration for eight 
weeks entrances the parameters suggested for obesity. Similar 
mechanisms could have contributed in increased body weight, altered 
lipid profile, enhanced fat depositions in the present study. 
When obese animals were subjected to physical exercise test for 
eight weeks, we found that there was significant difference 
(P<0.001) in body weight, lipid profile, fat deposition and blood-
glucose level compared to normal control (table 1-4). Physical 
exercise increases the metabolic rate in the body. It enhances the 
digested fat to provide energy. The regular exercise was also 
reported to enhance the breakdown of deposited fat contributed in 
reduced body weight, normalize altered lipid profile, and regulate 
blood-glucose. The earlier research indicated that exercised animals 
had increased in energy expenditure through exercise training and 
contributed in the over body weight gain and higher free fatty acid 
(FFA) mobilization from other adipose tissues[16]. Our study 
suggests that the similar mechanism might have followed in this 
study too when obese animals were subjected to exercise. 
The present study indicated that administration of LCD to the animals 
for eight weeks significantly (P<0.001) reversed the obesity 
parameters compared to normal control (table 1-4). The composition 
of LCD contains glucose, casein, Nacl, dextrin. LCD is a standard diet 
widely used experimentally to reduce obesity in animals. The earlier 
data indicated that LCD reduced obesity is due to reducing in 
circulating levels of glucose and lipid metabolites [17]. Our study 
suggests that the similar mechanism could have contributed to this 
study too when obese animals were substituted with LCD. 
When obese animals were subjected to physical exercise and LCD 
test for eight weeks, we found that there was faster enhancement 
(P<0.001) in the reversal of obesity parameters compared to normal 
control (table 1-4). Physical exercise and LCD mechanism have been 
discussed earlier suggesting that combination of the two 
mechanisms could have contributed in the reduction of obesity. 
The present study indicated that administration of Orlistat (200 
mg/kg) to the animals for eight weeks, significantly (P<0.001) 
reversed the obesity parameters compared to normal control (table 
1-4). Orlistat is a standard diet widely used experimentally to reduce 
obesity in animals. The earlier research indicated Orlistat shows 
pancreatic lipase inhibitor and decreased body weight pancreatic 
lipase inhibitor evidence by pancreatic lipase is the key enzyme for 
dietary fat digestion, and inhibition of the enzyme could be an 
effective way to alter fat absorption further data suggests that 
administration of Orlistat was effective in reversal of obesity 
parameters by the mechanism suggested in the literature [16]. 
Low dose of Orlistat suggests that administration of Orlistat (65 
mg/kg) has also shown the significant (P<0.001) decrease in the 
parameters suggested for obesity (table 1-4). When obese animals 
were subjected to combination physical exercise and low dose 
Orlistat (65 mg/kg) for eight weeks, we observed that the reversal in 
the obesity parameters was more prominent compared to individual 
exercise and low dose Orlistat groups. 
The results suggest that the mechanisms mentioned earlier for 
physical exercise, and Orlistat might have potentiated the anti-
obesity action when used in combination. Similar observations were 
found when a combination of LCD and low dose of Orlistat was 
tested in obese rats, suggesting that combination in more effective 
than the individual treatment (table 1-4). 
In addition, it was observed that triple combination of physical 
exercise, low dose of Orlistat (65 mg/kg) and LCD for eight weeks 
further suppressed the obesity parameters such as body weight, 
lipid profile, fat deposition and glucose metabolism in HFD rats 
(table 1-4). The mechanisms suggested in the earlier groups could 
have produced synergistic effects when used in combination. The 
observations indicate that exercise, low dose, Orlistat and LCD 
together and play a vital role in obese individual resistant to 
conventional anti-obesity therapies. 
CONCLUSION  
It can be concluded that [HFD+Orlistat (low dose)+Exercise+LCD] 
group was significant in reduced Body weight, Triglycerides, total 
cholesterol, Lipid parameters [HDL, VLDL, LDL], Blood-glucose level, 
organ weight [mesenteric fat and epididymal fat] and organ fat pad 
weight, when compared to HFD control.  
Exercise shows higher free fatty acid (FFA) mobilization from 
adipose tissue and LCD diets exhibit little changes in circulating 
levels of glucose and lipid metabolites, and Orlistat shows pancreatic 
lipase inhibitory activity because of that reason obesity rats are 
reducing body weight. 
The present study [HFD+Orlistat (low dose)+Exercise+LCD] group 
showed more potential effective than rest of all treatment groups.  
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